Crucially, the authors then went on to attenuate the expression of PKC-ε using an anti-sense oligonucelotide directed at PKC-ε and they noted that this protected the rats from steatosis-induced hepatic insulin resistance and also reversed defects that they had observed in insulin receptor signalling function. Here, PRKCE is linked to Insulin resistance.